Axogen, Inc. (AXGN) Form 8-K — Oct 28, 2026
Axogen reported Q3 2026 revenue of $75.8 million, up 26.2% year over year, with GAAP net income of $2.3 million ($0.04 per share) and adjusted EBITDA of $13.4 million (17.7% margin). The company raised full-year 2026 revenue guidance to at least $290 million (at least 29% growth), including at least $7 million from the newly acquired BioCircuit Technologies, and reiterated positive free cash flow expectations. Axogen closed an upsized $225 million public offering, used $200 million to fund the BioCircuit acquisition (maker of NerveTape), repaid all long-term debt, and now holds $350.1 million in cash with no debt obligations.
Key figures
- Eps
- 0.04
- Revenue
- 75800000
- Guidance
- Full-year 2026 revenue of at least $290 million (at least 29% growth), including at least $7 million from BioCircuit; organic revenue of at least $283 million (at least 26% growth); gross margin at least 73%; positive full-year free cash flow.
- Net Income
- 2300000
- Revenue Yoy
- 26.2%
- Cash Position
- 350100000
- Total debt
- $0 (long-term debt repaid; no debt obligations)
- Ytd revenue
- $207.0 million vs $165.3 million prior year
- Gross margin
- 74.8% (vs 76.6% Q3 2025)
- Total assets
- $550.3 million
- Ytd net loss
- $(18.8) million, including $16.8 million loss on extinguishment of debt
- Adjusted ebitda
- $13.4 million (17.7% margin) vs $9.2 million (15.4%) prior year
- Avance coverage
- approximately 96% of US covered lives
- Shares outstanding
- 59,724,524
- Ytd free cash flow
- $18.9 million vs $(5.9) million prior year
- Adjusted net income
- $13.1 million ($0.21/share diluted) vs $6.1 million ($0.12) prior year
- Net proceeds offering
- $225 million from sale of 5,646,500 shares
- Biocircuit acquisition funding
- $200 million used to fund BioCircuit acquisition; $1.9 million transaction expenses
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.